These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
500 related items for PubMed ID: 22102069
1. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study. Dyduch G, Okoń K, Pescarini E. Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069 [Abstract] [Full Text] [Related]
6. Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study. Feinmesser M, Veltman V, Morgenstern S, Tobar A, Gutman H, Kaganovsky E, Tzabari C, Sulkes J, Okon E. Am J Dermatopathol; 2010 Oct; 32(7):665-75. PubMed ID: 20559114 [Abstract] [Full Text] [Related]
8. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Harvima IT. J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999 [Abstract] [Full Text] [Related]
9. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329 [Abstract] [Full Text] [Related]
10. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi). Ko CJ, McNiff JM, Glusac EJ. J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111 [Abstract] [Full Text] [Related]
11. Evaluation of telomerase activity in cutaneous melanocytic proliferations. Miracco C, Pacenti L, Santopietro R, Laurini L, Biagioli M, Luzi P. Hum Pathol; 2000 Sep; 31(9):1018-21. PubMed ID: 11014565 [Abstract] [Full Text] [Related]
12. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR, El-Zammar O. Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [Abstract] [Full Text] [Related]
13. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study. Santucci M, Urso C, Giannini A, Bondi R. Appl Pathol; 1989 Apr; 7(2):111-5. PubMed ID: 2730799 [Abstract] [Full Text] [Related]
14. Prognostic significance of cytoplasmic p27 expression in human melanoma. Chen G, Cheng Y, Zhang Z, Martinka M, Li G. Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232 [Abstract] [Full Text] [Related]
15. Expression of fatty acid synthase (FASN) in oral nevi and melanoma. de Andrade BA, León JE, Carlos R, Delgado-Azañero W, Mosqueda-Taylor A, Graner E, de Almeida OP. Oral Dis; 2011 Nov; 17(8):808-12. PubMed ID: 21819495 [Abstract] [Full Text] [Related]
16. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M. J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [Abstract] [Full Text] [Related]
17. A retrospective look at dysplastic nevi. What were they in 1978 and how have they fared since? Cockerell CJ, Berson DS. Am J Dermatopathol; 1985 Jun; 7 Suppl():93-7. PubMed ID: 3940095 [Abstract] [Full Text] [Related]